To our knowledge, this is the largest clinico-biological cohort to examine the prevalence and the prognostic impact of both NY-ESO-1 and HLA-A subtypes in patients with mSS, and the first study in this population using a combination of real-world data and archival tissue samples. Here, HLA-A is linked to Marinesco-Sjogren syndrome.